Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study
Levine, J.; Schooler, N.R.; Severe, J.; Escobar, J.; Gelenberg, A.; Mandel, M.; Sovner, R.; Steinbook, R.
Advances in Biochemical Psychopharmacology 24: 483-493
1980
ISSN/ISBN: 0065-2229 PMID: 6996445 Document Number: 162611
Document emailed within 1 workday
Related Documents
Marder, S.R.; Van Putten, T.; Aravagiri, M.; Hubbard, J.W.; Hawes, E.M.; McKay, G.; Midha, K.K. 1989: Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine Psychopharmacology Bulletin 25(3): 479-482Jain, R.C.; Ananth, J.V.; Lehmann, H.E.; Ban, T.A. 1975: A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients Current Therapeutic Research 18(4): 585-589
Wei, F.C.; Jann, M.W.; Lin, H.N.; Piao-Chien, C.; Chang, W.H. 1996: A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy Journal of Clinical Psychiatry 57(7): 298-302
Goode, D.J.; Meltzer, H.Y.; Fang, V.S. 1981: Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication Biological Psychiatry 16(7): 653-662
Nanda, K.; Morrison, C.S.; Kwok, C.; Byamugisha, J.; Jones, L.; Sriplienchan, S.; Magwali, T. 2011: Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand Contraception 83(6): 542-548
Sterlin, C.; Augustin, E.; Ban, T.A.; Jarrold, L. 1971: Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative study Current Therapeutic Research 13(1): 50-52
Itil, T.M.; Hsu, W.; Saletu, B.; Klingenberg, H. 1971: Effects of fluphenazine hydrochloride on digital computer sleep prints of schizophrenic patients Diseases of the Nervous System 32(11): 751-758
Walker, C.A. 1983: A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients Pharmatherapeutica 3(5): 289-293
Náhunek, K.; Svestka, J.; Cesková, E.; Rysánek, R. 1979: Clinical comparison of oxyprothepin and clotepine in schizophrenic patients (controlled study) Activitas Nervosa Superior 21(3): 133-135
Fehlinger, R.; Mielke, U.; Fauk, D.; Seidel, K. 1986: Rheographic indications for reduced cerebral vasoconstriction after oral magnesium medication in tetanic patients, a double-blind, placebo-controlled trial Magnesium 5(2): 60-65
Vergara, L.; Amin, M.M.; Ban, T.A. 1977: A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, Ii Psychopharmacology Bulletin 13(3): 17-19
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Bühler, H.; Pirovino, M.; Akobiantz, A.; Altorfer, J.; Weitzel, M.; Maranta, E.; Schmid, M. 1982: Regression of liver cell adenoma. a follow-up study of three consecutive patients after discontinuation of oral contraceptive use Gastroenterology 82(4): 775-782
Bergener, M.; Husser, J.; Kranzhoff, E.U.; Charap, A. 1986: Long-term therapy with depot neuroleptics. Prevention of recurrence in chronic schizophrenic patients Fortschritte der Medizin 104(40): 756-760
Beksinska, M.E.; Kleinschmidt, I.; Smit, J.A.; Farley, T.M.M. 2009: Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate Contraception 79(5): 345-349
Baldini, J.T.; Neary, E.R. 1970: Controlled trials of an amitriptyline-fluphenazine combination in depressive neuroses and psychoses: a collaborative study Current Therapeutic Research 12(2): 84-93
Bozza, A.E.; Guimarães, F.J.; de Carvalho, F.J.; Santos, L.C.; Pellon, F.M.; de Castro, R.F.; Balbuena, R.R. 1984: Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy Arquivos Brasileiros de Cardiologia 43(3): 213-217
Schooler, N.R.; Levine, J.; Severe, J.B. 1979: Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen Psychopharmacology Bulletin 15(2): 44-47
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Cheewadhanaraks, S.; Choksuchat, C.; Dhanaworavibul, K.; Liabsuetrakul, T. 2012: Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial Gynecologic and Obstetric Investigation 74(2): 151-156